Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 14, 2023

SELL
$6.69 - $11.99 $370,017 - $663,154
-55,309 Reduced 12.69%
380,591 $3.25 Million
Q1 2023

May 15, 2023

SELL
$8.44 - $13.47 $2.9 Million - $4.64 Million
-344,100 Reduced 44.12%
435,900 $4.01 Million
Q4 2022

Feb 14, 2023

SELL
$9.71 - $15.86 $388,400 - $634,400
-40,000 Reduced 4.88%
780,000 $7.96 Million
Q3 2022

Nov 14, 2022

SELL
$10.96 - $15.45 $9.09 Million - $12.8 Million
-829,400 Reduced 50.28%
820,000 $12.1 Million
Q2 2022

Aug 15, 2022

SELL
$7.41 - $11.56 $4.49 Million - $7 Million
-605,600 Reduced 26.86%
1,649,400 $17.7 Million
Q1 2022

May 16, 2022

SELL
$9.89 - $17.25 $7.57 Million - $13.2 Million
-765,000 Reduced 25.33%
2,255,000 $24.3 Million
Q4 2021

Feb 14, 2022

BUY
$16.14 - $25.04 $14.6 Million - $22.6 Million
902,500 Added 42.62%
3,020,000 $49.3 Million
Q3 2021

Nov 15, 2021

BUY
$17.52 - $27.93 $37.1 Million - $59.1 Million
2,117,500 New
2,117,500 $45.3 Million

Others Institutions Holding CTKB

About Cytek Biosciences, Inc.


  • Ticker CTKB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 134,627,008
  • Market Cap $851M
  • Description
  • Cytek Biosciences, Inc., a cell analysis solutions company, provides cell analysis tools that facilitates scientific advances in biomedical research and clinical applications. It offers aurora and northern lights systems, which are spectrum flow cytometers that delivers cell analysis by utilizing the fluorescence signatures from multiple lasers ...
More about CTKB
Track This Portfolio

Track Miura Global Management, LLC Portfolio

Follow Miura Global Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Miura Global Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Miura Global Management, LLC with notifications on news.